Organization
Newcastle University
1 clinical trial
9 abstracts
Abstract
Node marking techniques and targeted axillary dissection in patients with cN1 disease undergoing neoadjuvant chemotherapy: Analysis of initial 500 participants in the ATNEC trial.Org: Royal Derby Hospital, University of Warwick, Aberdeen Royal Infirmary, Royal Cornwall Hospitals NHS Trust, Queen Elizabeth Hospital,
Abstract
A phase I study of highly potent oral ATR inhibitor (ATRi) tuvusertib plus oral PARP inhibitor (PARPi) niraparib in patients with solid tumors.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Newcastle University, Northern Centre for Cancer Care (NCCC), New Experimental Therapeutics (NEXT), Merck Serono Ltd.,
Clinical trial
Phase 1 Study of Autologous Tolerogenic Dendritic Cells for Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2018-11-01
Abstract
Performance analysis of four machine learning algorithms for the accurate prediction of metastatic disease in cutaneous squamous cell carcinoma.Org: National Health Service, Newcastle University, Royal Victoria Infirmary,
Abstract
Discovery and validation of AMBLor as a prognostic biomarker for non-ulcerated cutaneous AJCC stage I/II melanoma.Org: Newcastle University, Hospital Clinico Universitario de Valencia; INCLIVA; GEICAM Spanish Breast Cancer Group, University of Barcelona, Hospital Clinic of Barcelona, Dermatology Department,
Abstract
“LIKE A BAG OF LIQUORICE ALLSORTS – EVERYBODY'S GOT DIFFERENT FLAVOURS”: A QUALITATIVE FOCUS GROUP STUDY TO EXPLORE SYMPTOMS OF FATIGUE, SLEEP DISTURBANCES AND PAIN IN PRIMARY SJÖGREN'S SYNDROME PATIENTS AND TO DEVELOP A FUTUROrg: Newcastle University, Newcastle upon Tyne NHS Foundation Trust, Northumbria University, Newcastle upon Tyne, University of East Anglia, Norwich, United Kingdom,
Abstract
‘CLINICAL ASSESSMENT OF THE MUSCULOSKELETAL SYSTEM’ HANDBOOK AND ACCOMPANYING VIDEOS: 15 YEARS OF USEOrg: Newcastle University, Cardiff University School of Medicine, Versus Arthritis, City Hospitals Sunderland,
Abstract
ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIALOrg: King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, University of Birmingham, Sandwell and West Birmingham NHS Trust, Catholic University of the Sacred Heart, Rome, Italy,
Abstract
A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS)Org: UCB Pharma, Newcastle University, Strasbourg University Hospital, University of Palermo, Université Paris-Sud,
Abstract
AUTOLOGOUS STEM CELL TRANSPLANTATION INTERNATIONAL SCLERODERMA TRIAL Org: Newcastle University, Hopital Saint-Louis, University Hospital Basel and University of Basel,